Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nutrition of critically ill patients in intensive care].

Der Internist·2007
Same author

[Nutritional concepts for patients under intensive care].

Pneumologie (Stuttgart, Germany)·2007
Same author

[Current possibilities in artificial nutrition].

Therapeutische Umschau. Revue therapeutique·1995
Same author

Partitioning of 238Pu, 239Pu and 241Am in skeleton and liver of U.S. Transuranium Registry autopsy cases.

Health physics·1988
Same author

Endoscopy as final arbiter in controlled clinical trials in peptic disorders.

Clinics in gastroenterology·1986
Same author

Extended wear of Hydrocurve II55 soft contact lenses.

Journal of the American Optometric Association·1980
Same journal

From symptoms to standards: Integrating guidelines, validated tools, and dietary strategies in the care of Arabic-speaking patients with IBS and pelvic floor disorders.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

Disease burden of inflammatory bowel disease and subtypes in older adults in 172 high- and middle-income countries: Trends from 2000 to 2023 and projections to 2040.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

The unfinished success of hepatitis B control in Saudi Arabia: Concentrated burden in adult males and geographic notification hotspots in the post-vaccination era, 2019-2023.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

Association between residential greenness and the risk of inflammatory bowel disease in patients with COVID-19: A Korean nationwide cohort study.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm in each MRI sequence.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

Comment on global trends in the burden and quality of care for upper gastrointestinal diseases, 1990-2021.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Octreotide: a clinical update.

R F Meier1, M M Reichert

  • 1Department of Gastroenterology, University Hospital Liestal, Switzerland.

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Somatostatin and octreotide impact gastrointestinal functions by inhibiting secretion and motility. This review explores octreotide

Related Experiment Videos

Last Updated: Jun 19, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Pharmacology

Background:

  • Somatostatin is a peptide hormone found in the pancreas, gastrointestinal tract, and nervous system.
  • Its physiological roles as a hormone, paracrine substance, or neurotransmitter in the gut are not fully understood.
  • Octreotide, a potent synthetic somatostatin analogue, has a longer half-life and is used therapeutically.

Purpose of the Study:

  • To review the pharmacological effects of octreotide on various gastrointestinal functions.
  • To describe the therapeutic applications of octreotide in managing gastrointestinal disorders.

Main Methods:

  • Literature review of studies on somatostatin and octreotide.
  • Analysis of pharmacological data on octreotide's effects on gastrointestinal secretion, absorption, motility, and blood flow.
  • Examination of clinical evidence for octreotide in gastrointestinal diseases.

Main Results:

  • Octreotide inhibits neuroendocrine and exocrine gastrointestinal secretion.
  • It reduces intestinal transport of glucose, fats, and amino acids.
  • Octreotide decreases intestinal motility, gallbladder contraction, splanchnic blood flow, and hepatic venous pressure.

Conclusions:

  • Octreotide exhibits significant inhibitory effects on diverse gastrointestinal functions.
  • The extent of inhibition varies by target organ.
  • Octreotide holds therapeutic value in various gastrointestinal conditions.